Antwerp radiotherapy centre chooses TomoTherapy cancer treatment system
7 June 2007 Madison, Wis., USA. The new University Radiotherapy Centre
of Antwerp has chosen the TomoTherapy Hi·Art treatment system for providing
radiation therapy, and the Centre will serve as a European training facility
for TomoTherapy Incorporated (NASDAQ: TTPY).
Hospitals participating in the Centre include University Hospital Antwerp
and the Antwerp City Hospital Network. Two Hi·Art treatment systems have
been installed on-site at University Hospital Antwerp. Through the
University Radiotherapy Center, both member hospitals will use Hi·Art
treatment systems to treat cancer patients with advanced image-guided,
intensity-modulated radiation therapy (IG/IMRT).
And, through collaboration with TomoTherapy, the machines will also be
available for training physicians, hospital staff and TomoTherapy employees
while still providing uninterrupted patient care. International Marketing
Manager Chris Hasler said, “This partnership makes it possible to combine
training and patient care in a unique setting. The training component
demonstrates our commitment to the European market and to customer support.”
“The training centre is of particular importance for Antwerp University
Hospital,” says Antwerp University Hospital Head of Communication Tom
Meulenbergs. “As an academic centre of excellence, it places high value on
offering the best possible patient care through continuous innovation. The
combination of training and treatment centres fits seamlessly into this
picture.”
Creation of a training centre based in Europe is part of TomoTherapy’s
vision for global training. The centre will serve as a regional satellite of
the International Technical Training Center at company headquarters in
Madison, Wisconsin. To top
|